Seres Therapeutics, Inc. (MCRB)

Seres Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 13, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	64	142	181	698	765	2,236
Market Cap Growth	4.42%	-21.59%	-74.06%	-8.81%	-65.78%	825.56%
Enterprise Value	95	169	223	541	461	1,979
Last Close Price	7.37	16.62	28.00	112.00	166.60	490.00
PE Ratio	220.42	1043.26	-	-	-	-
PS Ratio	-	-	-	-	5.28	67.31
PB Ratio	1.28	10.29	-4.03	64.71	5.82	12.79
P/TBV Ratio	1.27	10.29	-	64.71	5.82	12.79
P/OCF Ratio	-	-	-	-	114.40	-
EV/Sales Ratio	-	-	-	-	3.18	59.60
Debt / Equity Ratio	1.77	6.65	-4.43	15.08	0.37	0.23
Asset Turnover	-	-	-	-	0.42	0.14
Quick Ratio	1.97	0.80	1.30	2.12	3.53	5.67
Current Ratio	2.11	0.94	1.78	2.28	3.69	5.79
Return on Equity (ROE)	-	-	-	-258.04%	-42.83%	-141.00%
Return on Assets (ROA)	-28.22%	-30.43%	-34.48%	-31.96%	-11.55%	-23.17%
Return on Capital (ROIC)	-48.44%	-58.47%	-74.51%	-63.51%	-20.34%	-51.97%
Earnings Yield	113.54%	0.10%	-62.84%	-35.85%	-8.57%	-3.99%
FCF Yield	-	-105.01%	-69.26%	-34.20%	-0.38%	-4.21%
Buyback Yield / Dilution	-32735.87%	-21.40%	-18.44%	-17.86%	-14.93%	-40.85%

Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q